Journal article
Economic Evaluation of the MEDENOX Trial: A Canadian Perspective
Abstract
OBJECTIVE: To perform an economic evaluation of the Prophylaxis in Medical Patients with Enoxaparin (MEDENOX) trial from a Canadian perspective.
METHOD: Using a decision tree model, cost effectiveness analysis was carried out to compare the costs and consequences of thromboprophylaxis using enoxaparin 40 mg with placebo in tertiary and community settings. From a third party payer's perspective, the model calculated the expected rate of …
Authors
Lamy A; Wang X; Kent R; Smith KM; Gafni A
Journal
Canadian Respiratory Journal, Vol. 9, No. 3, pp. 169–177
Publisher
Wiley
Publication Date
January 2002
DOI
10.1155/2002/310841
ISSN
1198-2241